Persistent Epstein-Barr virus DNA or its resurgence during treatment was associated with worse survival in patients with ...

Penpulimab has picked up a pair of approvals in nasopharyngeal carcinoma (NPC), becoming only the second drug to be cleared ...

Researchers with City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U ...

Nasopharyngeal carcinoma (NPC), originating from nasopharyngeal epithelium and frequently metastasizes to cervical lymph nodes and distal organs, is endemic in Southeast Asia and highly associated ...

Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV) associated malignancy characterized by a dense lymphocyte infiltrate and a complex tumor microenvironment (TME). This heterogenous ...

Merck & Co has entered into a worldwide licensing deal with Opko Health’s ModeX Therapeutics unit for a vaccine candidate against Epstein-Barr virus (EBV ... some forms of cancer and multiple ...

Head and neck cancer comprises a group of biologically similar cancers that start in the lip, oral cavity (mouth), nasal cavity (inside the nose), paranasal sinuses, pharynx and larynx.

While regions in Asia and Europe report low frequency of KSHV, research has revealed that up to 90% of the people in sub-Saharan Africa are living with this virus. For countries like Malawi and Uganda ...